OTC Markets EXMKT - Delayed Quote USD
Evelo Biosciences, Inc. (EVLO)
0.0005
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 25.75k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BODMER MARK Officer | Sale at price 0.33 per share. | Direct | 1,044 | Nov 8, 2023 |
MCHALE DUNCAN Officer | Sale at price 0.33 per share. | Direct | 1,024 | Nov 8, 2023 |
THORELL MARELLA Chief Financial Officer | Sale at price 0.33 per share. | Direct | 598 | Nov 8, 2023 |
GILL BALKRISHAN Chief Executive Officer | Sale at price 0.33 per share. | Direct | 57 | Nov 8, 2023 |
GILL BALKRISHAN Chief Executive Officer | -- | Direct | -- | Nov 7, 2023 |
BODMER MARK Officer | -- | Direct | -- | Nov 7, 2023 |
MCHALE DUNCAN Officer | -- | Direct | -- | Nov 7, 2023 |
THORELL MARELLA Chief Financial Officer | -- | Direct | -- | Nov 7, 2023 |
BODMER MARK Officer | Sale at price 0.33 per share. | Direct | 2,262 | Nov 2, 2023 |
MCHALE DUNCAN Officer | Sale at price 0.33 per share. | Direct | 2,262 | Nov 2, 2023 |
THORELL MARELLA Chief Financial Officer | Sale at price 0.33 per share. | Direct | 1,320 | Nov 2, 2023 |
BODMER MARK Officer | -- | Direct | -- | Nov 1, 2023 |
MCHALE DUNCAN Officer | -- | Direct | -- | Nov 1, 2023 |
THORELL MARELLA Chief Financial Officer | -- | Direct | -- | Nov 1, 2023 |
GILL BALKRISHAN Chief Executive Officer | Sale at price 3.94 per share. | Direct | 7,864 | Sep 28, 2023 |
GILL BALKRISHAN Chief Executive Officer | -- | Direct | -- | Sep 27, 2023 |
BODMER MARK Officer | Sale at price 9.51 per share. | Direct | 29,747 | Aug 8, 2023 |
MCHALE DUNCAN Officer | Sale at price 9.51 per share. | Direct | 32,657 | Aug 8, 2023 |
THORELL MARELLA Chief Financial Officer | Sale at price 9.51 per share. | Direct | 19,058 | Aug 8, 2023 |
GILL BALKRISHAN Chief Executive Officer | Sale at price 9.51 per share. | Direct | 3,252 | Aug 8, 2023 |
GILL BALKRISHAN Chief Executive Officer | -- | Direct | -- | Aug 7, 2023 |
BODMER MARK Officer | -- | Direct | -- | Aug 7, 2023 |
MCHALE DUNCAN Officer | -- | Direct | -- | Aug 7, 2023 |
THORELL MARELLA Chief Financial Officer | -- | Direct | -- | Aug 7, 2023 |
BODMER MARK Officer | Sale at price 0.14 per share. | Direct | 3,201 | May 23, 2023 |
BODMER MARK Officer | Sale at price 0.13 per share. | Direct | 8,536 | May 8, 2023 |
MCHALE DUNCAN Officer | Sale at price 0.13 per share. | Direct | 8,375 | May 8, 2023 |
THORELL MARELLA Chief Financial Officer | Sale at price 0.13 per share. | Direct | 4,836 | May 8, 2023 |
GILL BALKRISHAN Chief Executive Officer | Sale at price 0.13 per share. | Direct | 444 | May 8, 2023 |
GILL BALKRISHAN Chief Executive Officer | -- | Direct | -- | May 5, 2023 |
BODMER MARK Officer | -- | Direct | -- | May 5, 2023 |
MCHALE DUNCAN Officer | -- | Direct | -- | May 5, 2023 |
THORELL MARELLA Chief Financial Officer | -- | Direct | -- | May 5, 2023 |
Related Tickers
UCBJF UCB SA
150.70
0.00%
ELOX Eloxx Pharmaceuticals, Inc.
0.0001
0.00%
KZR Kezar Life Sciences, Inc.
4.5800
+1.78%
KLDO Kaleido Biosciences, Inc.
0.0050
0.00%
ZIVO ZIVO Bioscience, Inc.
16.00
+28.00%
MTEM Molecular Templates, Inc.
0.0001
0.00%
BTTX Better Therapeutics, Inc.
0.0002
0.00%
OPT Opthea Limited
3.4100
+1.49%
APGE Apogee Therapeutics, Inc.
36.53
+2.90%
LIXT Lixte Biotechnology Holdings, Inc.
1.3000
+15.04%